brief hx: a 54-year-old male patient with liver nodule for further evaluation.
  this study has been compared with the previous study on 2012.07.06.
  
  mri of the liver, pulse sequences:
    axl t1wi , t2wi , and long t2wi, 5 mm in thickness and 2 mm gap for whole liver; 
  axl  t1wic+ 15 sec after iv infusion of gd-dtpa 0.2ml/kg, 5 mm in thickness and 2 
  mm gap for whole liver, followed by 30 sec intervals for the 2nd and 3rd t1wi c+.
  
  finding:
  lobulated contour of liver compatible with liver cirrhosis. 
  splenomegaly  
  the liver parenchyma revealed diffue higher signal intensity on t1wi, and lower 
  signal intensity on t2wi than spleen, compatible with fatty liver.   
   a 1.2 cm lesion in high s7 liver with low signal intensity on t1wi, mild high 
  signal intensity on t2wi and long t2wi, early enhancement with early washed out 
  and low signal intensity on hepatobiliary phases, favor hcc.
  no definite biliary dilatation. 
  patency of portal vein. 
  no definite obstructive uropathy. 
  no abnormal fluid collection in the abdomen. 
  
  ¡´imaging report form for hepatocellua carcinoma (ajcc 7th edition)
  1.tumor number/location: 
      number: ¡´1 ¡³2 ¡³3 ¡³multiple:
      location:  s7 
  2.tumor size: 
      ¡´measurable: 1.2 cm (the largest tumor)
      ¡³non-measurable
  3.tumor characteristics and associated liver features
      ¡³vascular invasion 
      ¡³extrahepatic spread 
      ¡³ascites 
      ¡³portal vein thrombosis, location 
      ¡³portosystemic collateral vessel
      ¡´typical enhancement pattern (hypervascular enhancement and early wash-out)
  3.pathology: ¡´not available ¡³available (pathology type:¡¼)
  
  -------------------primary tumor(t)--------------------------
   tx    ¡³primary tumor cannot be assessed 
   t0    ¡³no primary tumor 
  stage i
   t1    ¡´solitary tumor without vascular invasion 
  stage ii
   t2    ¡³solitary tumor with vascular invasion
         ¡³multiple tumors none more than 5 cm
  stage iii
   a t3a ¡³multiple tumors more than 5 cm 
   b t3b ¡³single tumor or multiple tumors of any size
         involving a major branch of the portal vein or
         hepatic vein 
   c t4  ¡³tumor(s) with direct invasion of ivc, adjacent
         organs other than the gallbladder or with
         perforation of visceral peritoneum. 
  -------------------regional lymph nodes(n)-----------------
   nx    ¡³regional lymph nodes cannot be assessed 
   n0    ¡´no regional lymph nodes
  stage iva
   n1    ¡³regional lymph node metastasis 
          ¡³periceliac, ¡³hilar( common bile duct, hepatic artery, portal vein and 
  cystic duct) ¡³peripancreatic ¡³paraaortic ¡³portocaval ¡³retrocaval 
  ¡³others_______ 
  -------------------distant metastasis(m)----------------------
  stage ivb
   m1    ¡³distant metastasis
  ¡³	invasion of gallbladderfindings: 
s/p tae with partial lipiodol retention in s6 liver mass (10.2cm) 
perihepatic stranding around s6 liver. tumor or inflammatory infiltration?
no definite biliary tree dilatation  .
patency of portal vein  
no gallbladder wall thickening or pericholecystic inflammatory stranding . 
no definite space-occupying lesion in the spleen and pancreas. 
no hydronephrosis 
bil. kidneys are well opacified with no apparent focal pelvicalyceal obstructive
 lesion 
patency of bil. ureter(s).
no definite enlargement of retroperitoneal lns . 
no enlarged lymph node in the pelvis 
no abnormal fluid or free air in the abdomen . 

 impression: 
1. s/p tae with partial lipiodol retention in s6 liver mass (10.2cm).  hcc?
2. perihepatic stranding around s6 liver. tumor or inflammatory infiltration?

¡´imaging report form for hepatocellua carcinoma (ajcc 8th edition)
1.tumor number/location: 
number: ¡´1 ¡³2 ¡³3 multiple:
location: s6 
2.tumor size: 
    ¡´measurable: 10.2cm (the largest tumor)
    ¡³non-measurable
3.tumor characteristics and associated liver features
    ¡³vascular invasion 
    ¡³extrahepatic spread 
    ¡³ascites 
    ¡³portal vein thrombosis, location 
    ¡³portosystemic collateral vessel
    ¡³typical enhancement pattern (hypervascular enhancement and early wash-out)
3.pathology: ¡³not available ¡³available (pathology type: liver, segment 5/6, 
segmentectomy 
      ----- hepatocellular carcinoma, moderately differentiate)

-------------------primary tumor(t)--------------------------
 tx  ¡³ primary tumor cannot be assessed 
 t0  ¡³ no primary tumor 
stage i
t1   ¡³ solitary tumor ¡Ø2 cm, or > 2cm without vascular invasion
t1a  solitary tumor ¡Ø2 cm
t1b  solitary tumor > 2cm without vascular invasion
stage ii
t2   ¡´ solitary tumor >2cm with vascular invasion, or multiple tumors,none >5
cm 
stage iii
t3   ¡³multiple tumors more than 5 cm 
t4   ¡³tsingle tumor or multiple tumors of any size involving a major
branch of the portal vein or hepatic vein, or tumor(s) with direct
invasion of adjacent organs other than the gallbladder or with
perforation of visceral peritoneum 
-------------------regional lymph nodes(n)-----------------
nx   ¡³regional lymph nodes cannot be assessed 
n0   ¡´no regional lymph nodes
stage iva
n1   ¡³regional lymph node metastasis 
     ¡³periceliac, ¡³hilar( common bile duct, hepatic artery, portal vein and 
cystic duct) ¡³peripancreatic ¡³paraaortic ¡³portocaval ¡³retrocaval
¡³others_______ 
-------------------distant metastasis(m)----------------------
stage ivb
m1  ¡³distant metastasis
¡³	invasion of gallbladder
¡³	cardiophrenic, mesenteric, retrocrural ln
imaging stage   t2 n0( in this study)
  ¡³	cardiophrenic, mesenteric, retrocrural ln
  imaging stage   t1 n0( in this study)
  
  imp.: 
  (1) liver cirrhosis, fatty liver change and splenomegaly. 
  (2) a 1.2 cm hcc in high s7 liver, imaging stage: t1n0( in this study).